Lixte Biotechnology Holdings, Inc.
LIXT
$3.29
-$0.0009-0.03%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 714.20K | 615.50K | 578.70K | 621.60K | 798.40K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 774.80K | 706.90K | 613.50K | 983.30K | 1.01M |
Operating Income | -774.80K | -706.90K | -613.50K | -983.30K | -1.01M |
Income Before Tax | -775.70K | -709.60K | -617.70K | -986.00K | -1.01M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -775.70K | -709.60K | -617.70K | -986.00K | -1.01M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -775.70K | -709.60K | -617.70K | -986.00K | -1.01M |
EBIT | -774.80K | -706.90K | -613.50K | -983.30K | -1.01M |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -0.29 | -0.29 | -0.27 | -0.44 | -0.45 |
Normalized Basic EPS | -0.18 | -0.18 | -0.17 | -0.27 | -0.28 |
EPS Diluted | -0.29 | -0.29 | -0.27 | -0.44 | -0.45 |
Normalized Diluted EPS | -0.18 | -0.18 | -0.17 | -0.27 | -0.28 |
Average Basic Shares Outstanding | 2.72M | 2.47M | 2.25M | 2.25M | 2.25M |
Average Diluted Shares Outstanding | 2.72M | 2.47M | 2.25M | 2.25M | 2.25M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |